Increased skin tumorigenesis in mice lacking pi class glutathione <i>S</i> -transferases

DOI Web Site 6 Citations
  • Colin J. Henderson
    Imperial Cancer Research Fund Molecular Pharmacology Unit, Biomedical Research Centre, Level 5, Ninewells Hospital and Medical School, Dundee, DD1 9SY, United Kingdom; Gene Targeting Laboratory, Centre for Genome Research, University of Edinburgh, King’s Buildings, West Mains Road, Edinburgh, EH9 3JQ, United Kingdom; and Molecular Carcinogenesis Group, CRC Beatson Laboratories, Department of Medical Oncology, Alexander Stone Building, Switchback Road, Garscube Estate, Glasgow, G61 1BD, United Kingdom
  • Austin G. Smith
    Imperial Cancer Research Fund Molecular Pharmacology Unit, Biomedical Research Centre, Level 5, Ninewells Hospital and Medical School, Dundee, DD1 9SY, United Kingdom; Gene Targeting Laboratory, Centre for Genome Research, University of Edinburgh, King’s Buildings, West Mains Road, Edinburgh, EH9 3JQ, United Kingdom; and Molecular Carcinogenesis Group, CRC Beatson Laboratories, Department of Medical Oncology, Alexander Stone Building, Switchback Road, Garscube Estate, Glasgow, G61 1BD, United Kingdom
  • Jan Ure
    Imperial Cancer Research Fund Molecular Pharmacology Unit, Biomedical Research Centre, Level 5, Ninewells Hospital and Medical School, Dundee, DD1 9SY, United Kingdom; Gene Targeting Laboratory, Centre for Genome Research, University of Edinburgh, King’s Buildings, West Mains Road, Edinburgh, EH9 3JQ, United Kingdom; and Molecular Carcinogenesis Group, CRC Beatson Laboratories, Department of Medical Oncology, Alexander Stone Building, Switchback Road, Garscube Estate, Glasgow, G61 1BD, United Kingdom
  • Ken Brown
    Imperial Cancer Research Fund Molecular Pharmacology Unit, Biomedical Research Centre, Level 5, Ninewells Hospital and Medical School, Dundee, DD1 9SY, United Kingdom; Gene Targeting Laboratory, Centre for Genome Research, University of Edinburgh, King’s Buildings, West Mains Road, Edinburgh, EH9 3JQ, United Kingdom; and Molecular Carcinogenesis Group, CRC Beatson Laboratories, Department of Medical Oncology, Alexander Stone Building, Switchback Road, Garscube Estate, Glasgow, G61 1BD, United Kingdom
  • E. Jane Bacon
    Imperial Cancer Research Fund Molecular Pharmacology Unit, Biomedical Research Centre, Level 5, Ninewells Hospital and Medical School, Dundee, DD1 9SY, United Kingdom; Gene Targeting Laboratory, Centre for Genome Research, University of Edinburgh, King’s Buildings, West Mains Road, Edinburgh, EH9 3JQ, United Kingdom; and Molecular Carcinogenesis Group, CRC Beatson Laboratories, Department of Medical Oncology, Alexander Stone Building, Switchback Road, Garscube Estate, Glasgow, G61 1BD, United Kingdom
  • C. Roland Wolf
    Imperial Cancer Research Fund Molecular Pharmacology Unit, Biomedical Research Centre, Level 5, Ninewells Hospital and Medical School, Dundee, DD1 9SY, United Kingdom; Gene Targeting Laboratory, Centre for Genome Research, University of Edinburgh, King’s Buildings, West Mains Road, Edinburgh, EH9 3JQ, United Kingdom; and Molecular Carcinogenesis Group, CRC Beatson Laboratories, Department of Medical Oncology, Alexander Stone Building, Switchback Road, Garscube Estate, Glasgow, G61 1BD, United Kingdom

Search this article

Description

<jats:p> The activity of chemical carcinogens is a complex balance between metabolic activation by cytochrome P450 monooxygenases and detoxification by enzymes such as glutathione <jats:italic>S</jats:italic> -transferase (GST). Regulation of these proteins may have profound effects on carcinogenic activity, although it has proved impossible to ascribe the observed effects to the activity of a single protein. GstP appears to play a very important role in carcinogenesis, although the precise nature of its involvement is unclear. We have deleted the murine <jats:italic>GstP</jats:italic> gene cluster and established the effects on skin tumorigenesis induced by the polycyclic aromatic hydrocarbon 7,12-dimethylbenz anthracene and the tumor promoting agent 12- <jats:italic>O</jats:italic> -tetradecanoylphorbol-13-acetate. After 20 weeks, a highly significant increase in the number of papillomas was found in the <jats:italic>GstP1/P2</jats:italic> null mice [ <jats:italic>GstP1/P2</jats:italic> <jats:sup>(−/−)</jats:sup> mice, 179 papillomas, mean 9.94 per animal vs. <jats:italic>GstP1/P2</jats:italic> <jats:sup>(+/+)</jats:sup> mice, 55 papillomas, mean 2.89 per animal, ( <jats:italic>P</jats:italic> < 0.001)]. This difference in tumor incidence provides direct evidence that a single gene involved in drug metabolism can have a profound effect on tumorigenicity, and demonstrates that GstP may be an important determinant in cancer susceptibility, particularly in diseases where exposure to polycyclic aromatic hydrocarbons is involved, for instance in cigarette smoke-induced lung cancer. </jats:p>

Journal

Citations (6)*help

See more

Details 詳細情報について

Report a problem

Back to top